263868-71-9 Usage
Uses
Used in Pharmaceutical Development:
5-(Tributylstannyl)-2-(trimethylsilyl)thiazole is used as a potential candidate in pharmaceutical development due to its diverse biological activities, including antibacterial, antifungal, and antitumor properties. The unique combination of organostannyl and trimethylsilyl groups may contribute to its effectiveness in treating various diseases and conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 5-(Tributylstannyl)-2-(trimethylsilyl)thiazole is used as a reagent for chemical reactions. Its specific structural features and reactivity may enable the synthesis of new compounds with potential applications in various industries, such as pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 263868-71-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,8,6 and 8 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 263868-71:
(8*2)+(7*6)+(6*3)+(5*8)+(4*6)+(3*8)+(2*7)+(1*1)=179
179 % 10 = 9
So 263868-71-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H10NSSi.3C4H9.Sn/c1-9(2,3)6-7-4-5-8-6;3*1-3-4-2;/h4H,1-3H3;3*1,3-4H2,2H3;/rC18H37NSSiSn/c1-7-10-13-22(14-11-8-2,15-12-9-3)17-16-19-18(20-17)21(4,5)6/h16H,7-15H2,1-6H3
263868-71-9Relevant articles and documents
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
-
Page/Page column 85, (2010/11/29)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
HETEROCYCLIC COMPOUNDS
-
Page/Page column 12, (2008/06/13)
Compounds of formula I : and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and the use of such compounds and compositions for use in therapy.
